Beckman Coulter, Inc.
Beckman Coulter – Access Interleukin-6 (IL-6)
The Access Interleukin-6 (IL-6) assay is a fully automated immunoassay designed to measure the IL-6 level in serum and plasma which can be used to assist in identifying severe inflammatory response in patients with confirmed COVID-19 illness to aid in determining the risk of intubation with mechanical ventilation, in conjunction with clinical findings and the results of other laboratory testing.
· Preliminary studies have shown that IL-6 levels are elevated in patients with severe COVID-19 and IL-6 may contribute to the severe inflammatory response, also sometimes referred to as cytokine storm.1
· Elevated levels of IL-6 may be an early indicator that a patient is at risk of cytokine storm and acute respiratory distress 2,3
3 Maurizio, C at al. “Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection 4 Mehta P, McAuley DF